Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease.
Gente K, Feisst M, Marx D, Klika KD, Christopoulos P, Graf J, Will J, Luft T, Hassel JC, Müller-Tidow C, Carvalho RA, Lorenz HM, Souto-Carneiro MM.
Gente K, et al. Among authors: will j.
Ann Rheum Dis. 2024 Apr 1:ard-2023-224839. doi: 10.1136/ard-2023-224839. Online ahead of print.
Ann Rheum Dis. 2024.
PMID: 38561219
Free article.